daklinza
bristol-myers squibb pharma eeig - daclatasvir dihydrochloride - hepatitis c, kronični - antivirusni lijekovi za sustavnu uporabu - daklinza je indiciran u kombinaciji s drugim lijekovima za liječenje infekcije kroničnog hepatitisa c (hcv) kod odraslih (vidi odjeljke 4. 2, 4. 4 i 5. za specifične aktivnosti genotip hcv, vidi 4. 4 i 5.
inrebic
bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - antineoplastična sredstva - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.
orladeyo
biocryst ireland limited - berotralstat dihydrochloride - angioedemas, nasljedni - other hematological agents - orladeyo is indicated for routine prevention of recurrent attacks of hereditary angioedema (hae) in adult and adolescent patients aged 12 years and older.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukemija, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
azaran 1 g/1 viala prašak za rastvor za injekciju/infuziju
hemofarm proizvodnja farmaceutskih proizvoda d.o.o. banja luka - ceftriakson - prašak za rastvor za injekciju/infuziju - 1 g/1 viala - 1 bočica sa praškom za rastvor za injekciju/infuziju sadrži: 1 g ceftriakson (u obliku ceftriaksondinatrijum, triseskvihidrata)
propanorm 150 mg/1 tableta film tableta
pro.med. bh d.o.o. - пропафенона - film tableta - 150 mg/1 tableta - 1 tableta sadrži 150 mg propafenona
fortum 1 g/1 viala prašak za rastvor za injekciju
glaxosmithkline d.o.o.sarajevo - ceftazidim - prašak za rastvor za injekciju - 1 g/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 1,0 g ceftazidima (u obliku ceftazidim, pentahidrata)
tylol cold syrup 160 mg/5 ml+ 1 mg/5 ml+ 5 mg/5 ml+ 15 mg/5 ml sirup
nobel lijek d.o.o. sarajevo - dekstrometorfan, hlorfenamin, paracetamol, pseudoefedrin - sirup - 160 mg/5 ml+ 1 mg/5 ml+ 5 mg/5 ml+ 15 mg/5 ml - 5 ml sirupa sadrži: 160 mg paracetamol 1 mg hlorfenaminmaleat 5 mg dekstrometorfan hidrobromid 15 mg pseudoefedrinhidrohlorid
fortum 500 mg/1 viala prašak za rastvor za injekciju
glaxosmithkline d.o.o.sarajevo - ceftazidim - prašak za rastvor za injekciju - 500 mg/1 viala - 1 bočica sa praškom za rastvor za injekciju sadrži: 500 mg ceftazidim (u obliku ceftazidim, pentahidrata)